Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Heatstroke & supplements

This article was originally published in The Tan Sheet

Executive Summary

Ephedrine, creatine use may be responsible for recent upswing in heatstroke-related deaths in football, Julian Bailes, MD, West Virginia University, et al., contend in an editorial in the August Neurosurgery. Since 1995, 15 football players have died of heatstroke, compared to only six deaths from 1985 to 1994, researchers report, citing National Center for Catastrophic Sports Injury Research data. This upswing "may, in part, be attributable to or aggravated by the use of dietary supplements," Bailes et al. say. They cite evidence that "creatine usage causes shifts of body water into skeletal muscle cells" that may result in "unsuspected depletion in intravascular volume." Researchers suggest improving education for athletes, trainers and coaches about "dangers," misuse and potential adverse effects of supplements...

You may also be interested in...

Reimbursement Questions Jeopardize Hillrom/Bardy Merger

Hillrom is reconsidering its planned $375m acquisition of Bardy Diagnostics because of Novitas' plan to cut Medicare reimbursement for extended cardiac monitoring. Bardy is suing to complete the deal.

Boston Scientific Pays More Than $1Bn For Lumenis’ Surgical Laser Business

Lumenis’ surgical business includes the MOSES laser system for minimally invasive urology surgery which will complement Boston Scientific’s LithoVue ureteroscope.

Finance Watch: Eleven Companies Reveal $1.45bn In $100m-Plus VC Deals

Private Company Edition: Clover’s $230m financing was the largest of recent mega-rounds. Century Therapeutics ($160m), Vividion ($135m) and eGenesis ($125m) also raised big rounds and investors Foresite Capital ($969m), Sofinnova Partners ($540m) and OMX Ventures ($150m) raised new VC funds. 





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts